158 related articles for article (PubMed ID: 23529028)
41. Salicylanilide diethyl phosphates as potential inhibitors of some mycobacterial enzymes.
Krátký M; Novotná E; Saxena S; Yogeeswari P; Sriram D; Švarcová M; Vinšová J
ScientificWorldJournal; 2014; 2014():703053. PubMed ID: 25538961
[TBL] [Abstract][Full Text] [Related]
42. Synthesis of various 3-nitropropionamides as Mycobacterium tuberculosis isocitrate lyase inhibitor.
Sriram D; Yogeeswari P; Methuku S; Vyas DR; Senthilkumar P; Alvala M; Jeankumar VU
Bioorg Med Chem Lett; 2011 Sep; 21(18):5149-54. PubMed ID: 21840711
[TBL] [Abstract][Full Text] [Related]
43. Heterocyclic benzazole derivatives with antimycobacterial in vitro activity.
Kocí J; Klimesová V; Waisser K; Kaustová J; Dahse HM; Möllmann U
Bioorg Med Chem Lett; 2002 Nov; 12(22):3275-8. PubMed ID: 12392731
[TBL] [Abstract][Full Text] [Related]
44. Highly active antimycobacterial derivatives of benzoxazine.
Petrlíková E; Waisser K; Divišová H; Husáková P; Vrabcová P; Kuneš J; Kolář K; Stolaříková J
Bioorg Med Chem; 2010 Dec; 18(23):8178-87. PubMed ID: 21044844
[TBL] [Abstract][Full Text] [Related]
45. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L
Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398
[TBL] [Abstract][Full Text] [Related]
46. Design, Synthesis, and Biological Evaluation of Isothiosemicarbazones with Antimycobacterial Activity.
Novotná E; Waisser K; Kuneš J; Palát K; Skálová L; Szotáková B; Buchta V; Stolaříková J; Ulmann V; Pávová M; Weber J; Komrsková J; Hašková P; Vokřál I; Wsól V
Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28635184
[TBL] [Abstract][Full Text] [Related]
47. 1-Aryl-5-benzylsulfanyltetrazoles, a new group of antimycobacterial compounds against potentially pathogenic strains.
Waisser K; Adamec J; Dolezal R; Kaustová J
Folia Microbiol (Praha); 2005; 50(3):195-7. PubMed ID: 16295656
[TBL] [Abstract][Full Text] [Related]
48. Bio-evaluation of fluoro and trifluoromethyl-substituted salicylanilides against multidrug-resistant
Lal J; Kaul G; Akhir A; Ansari SB; Chopra S; Reddy DN
Med Chem Res; 2021; 30(12):2301-2315. PubMed ID: 34720564
[TBL] [Abstract][Full Text] [Related]
49. Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth.
Wallace RJ; Nash DR; Steele LC; Steingrube V
J Clin Microbiol; 1986 Dec; 24(6):976-81. PubMed ID: 3097069
[TBL] [Abstract][Full Text] [Related]
50. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium.
Collins L; Franzblau SG
Antimicrob Agents Chemother; 1997 May; 41(5):1004-9. PubMed ID: 9145860
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and Biological Evaluation of N-Alkoxyphenyl-3-hydroxynaphthalene-2-carboxanilides.
Gonec T; Zadrazilova I; Nevin E; Kauerova T; Pesko M; Kos J; Oravec M; Kollar P; Coffey A; O'Mahony J; Cizek A; Kralova K; Jampilek J
Molecules; 2015 May; 20(6):9767-87. PubMed ID: 26023938
[TBL] [Abstract][Full Text] [Related]
52. Ring-substituted 8-hydroxyquinoline-2-carboxanilides as potential antimycobacterial agents.
Kos J; Zadrazilova I; Nevin E; Soral M; Gonec T; Kollar P; Oravec M; Coffey A; O'Mahony J; Liptaj T; Kralova K; Jampilek J
Bioorg Med Chem; 2015 Aug; 23(15):4188-4196. PubMed ID: 26183541
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and evaluation of new 4-oxoquinazolin-3(4H)-yl)benzoic acid and benzamide derivatives as potent antibacterial agents effective against multidrug resistant Staphylococcus aureus.
Gatadi S; Gour J; Shukla M; Kaul G; das S; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
Bioorg Chem; 2019 Mar; 83():569-579. PubMed ID: 30471579
[TBL] [Abstract][Full Text] [Related]
54. In Vitro Activities of LCB 01-0648, a Novel Oxazolidinone, against Gram-Positive Bacteria.
Oh SH; Kim J; Baek SY; Chae SE; Park HS; Cho YL; Kwak JH
Molecules; 2017 Mar; 22(3):. PubMed ID: 28273820
[TBL] [Abstract][Full Text] [Related]
55. Determination of in vitro susceptibility of mycobacteria to ansamycin.
Heifets LB; Iseman MD
Am Rev Respir Dis; 1985 Sep; 132(3):710-1. PubMed ID: 3929660
[TBL] [Abstract][Full Text] [Related]
56. Thiacetazone: in vitro activity against Mycobacterium avium and M. tuberculosis.
Heifets LB; Lindholm-Levy PJ; Flory M
Tubercle; 1990 Dec; 71(4):287-91. PubMed ID: 1702564
[TBL] [Abstract][Full Text] [Related]
57. Salicylanilide acetates: synthesis and antibacterial evaluation.
Vinsova J; Imramovsky A; Buchta V; Ceckova M; Dolezal M; Staud F; Jampilek J; Kaustova J
Molecules; 2007 Jan; 12(1):1-12. PubMed ID: 17693949
[TBL] [Abstract][Full Text] [Related]
58. A duplicated nitrotienyl derivative with antimycobacterial activity: synthesis, X-ray crystallography, biological and mutagenic activity tests.
Rando DG; Doriguetto AC; Tomich de Paula da Silva CH; Ellena J; Sato DN; Leite CQ; Varanda EA; Ferreira EI
Eur J Med Chem; 2006 Oct; 41(10):1196-200. PubMed ID: 16828526
[TBL] [Abstract][Full Text] [Related]
59. New series of isoniazid hydrazones linked with electron-withdrawing substituents.
Vavříková E; Polanc S; Kočevar M; Košmrlj J; Horváti K; Bosze S; Stolaříková J; Imramovský A; Vinšová J
Eur J Med Chem; 2011 Dec; 46(12):5902-9. PubMed ID: 22018878
[TBL] [Abstract][Full Text] [Related]
60. In vitro activity of retapamulin against linezolid and methicillin-resistant Staphylococcus aureus isolates.
Candel FJ; Morales G; Picazo JJ
Rev Esp Quimioter; 2011 Sep; 24(3):127-30. PubMed ID: 21947094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
